New incident report
Incident Report Number: 2016-0697
Registrant Reference Number: 2015KP332
Registrant Name (Full Legal Name no abbreviations): Bayer Inc
Address: 2920 matheson BLVD
City: Mississaugua
Prov / State: ON
Country: Canada
Postal Code: L4W 5R6
Domestic Animal
Country: UNITED STATES
Prov / State: UNKNOWN
PMRA Registration No. PMRA Submission No. EPA Registration No. 11556-120
Product Name: advantage 55
Liquid
Yes
Units: mL
Site: Animal / Usage sur un animal domestique
No
Other
Cat / Chat
Domestic Shorthair
1
Male
Female
8
15
lbs
Skin
>1 wk <=1 mo / > 1 sem < = 1 mois
>24 hrs <=3 days / >24 h <=3 jours
System
>3 days <=1 wk / >3 jours <=1 sem
No
No
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On approximately 25-Oct-2015, the cat had hiding behavior, decreased vocalization, anorexia, lethargy and urinary tenesmus. On 28-Oct-2015, the cat had vocalization and was found by the owner deceased with evidence of hypersalivation. On 30-Oct-2015, a necropsy was performed. Gross diagnostic report indicated severe left ventricular and septal concentric hypertrophy and left atrial dilation; hydrothorax and pulmonary congestion; and chronic neprhitis unilateral (right) and acute cortical necrosis (left). Left-sided congestive heart failure and cardiac arrest due to primary hypertrophic cardiomyopathy were interpreted as the cause of death. The acute unilateral cortical necrosis of the left kidney was attributed to a vascular event (thromboembolism). No more information is expected. This case is closed.
Death
Offlabel use of the product occurred as dog product was used on cat. Reported signs hiding, decreased vocalization, anorexia, lethargy are unspecific and may be associated with urinary tenesmus. Moreover, urinary tenesmus is not expected after product application as sign is not in line with products pharmaco-toxicological profile. Time to onset is short though. Reported vocalization and hypersalivation are also unspecific and may have various other causes. Death not expected after product application, as inconsistent with pharmaco-toxicological product profile. As per necropsy results, animal was died due to cardiac arrest, thus death is not product related. Clinical conditions observed during necropsy are not in expected after product application as signs are not line with products pharmaco-toxicological profile. Product was used before without any side effects. No signs of allergic/anaphylactic reaction reported and time to onset is long for death. Considering all aspects, sufficient information exists to ruled out product relation completely. Overall, a product relation considered as unlikely.